What Researchers Did
The authors looked at published case series of people who developed bone death in the jaw (osteonecrosis of the jaw, or ONJ) while taking a group of bone drugs called bisphosphonates.
What They Found
In an analysis of case series, ONJ appeared to be associated with bisphosphonates, but the abstract gives no numbers for how common it is. The abstract says the biology of the condition, how often it occurs, and the other health conditions involved still need more study. The main risk factors identified so far were cancer (or chemotherapy for cancer) and dental procedures or oral trauma. The authors also said a clear definition of ONJ is critical, and that clinical studies are needed to set firmer guidelines for managing it.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This was an analysis of case series, which cannot show cause and effect, and the abstract reports no comparison group, no numerical results and no data supporting the hyperbaric oxygen statement.